Table 4:
Absolute Risk Difference (%) | Odds Ratio (95% CI) | |
---|---|---|
Funding | ||
Funded | −0.02 | 0.91 (0.28–2.99) |
Not Funded | Ref | Ref |
Study Design | ||
Experimental | −0.09 | 0.60 (0.16–2.21) |
Non-experimental | Ref | Ref |
Sample Size | ||
4–93 (Quartile 1) | Ref | Ref |
100–264 (Quartile 2) | −0.07 | 0.66 (0.19–2.34) |
278–1295 (Quartile 3) | −0.13 | 0.49 (0.15–1.55) |
1508–4 352 082 (Quartile 4) | 0.12 | 0.53 (0.15–1.91) |
Continuum Level | ||
Risk Assessment | −0.14 | 0.49 (0.08–2.94) |
Prevention | Ref | Ref |
Detection | −0.12 | 0.52 (0.12–2.20) |
Diagnosis | −77** | 0.01 (0.001–0.17) |
Treatment | −39* | 0.16 (0.03–0.91) |
HIT Intervention Focus | ||
Patient | −31* | 0.19 (0.04–0.86) |
Provider | Ref | Ref |
Both | −0.07 | 0.70 (0.05–9.62) |
Study Outcomes | ||
Behavior Change | −41** | 0.14 (0.03–0.57) |
Decision Making | +27* | 5.80 (1.15–29.38) |
Psychosocial | −30 | 0.25 (0.03–2.47) |
*P < .05.
**P < .01.